tiprankstipranks
Arvinas Holding Company (ARVN)
NASDAQ:ARVN
US Market
ARVN
Arvinas Holding Company
RESEARCH TOOLSreports

Arvinas Holding Company (ARVN) Stock News & Sentiment

1,044 Followers
Arvinas Buy Rating Driven by Robust ARV-102 LRRK2 Degrader Data and Clear Neurodegeneration Development Path
Premium
Ratings
Arvinas Buy Rating Driven by Robust ARV-102 LRRK2 Degrader Data and Clear Neurodegeneration Development Path
23d ago
ARVN
Balanced View on Arvinas: Early Promise of ARV-102 Offset by Clinical, Safety, and Competitive Uncertainties Supporting a Hold Rating
Premium
Ratings
Balanced View on Arvinas: Early Promise of ARV-102 Offset by Clinical, Safety, and Competitive Uncertainties Supporting a Hold Rating
23d ago
ARVN
ARV-102 Data Strengthens Neurodegeneration Pipeline Prospects, Supporting Higher $16 Target and Buy Rating on Arvinas
Premium
Ratings
ARV-102 Data Strengthens Neurodegeneration Pipeline Prospects, Supporting Higher $16 Target and Buy Rating on Arvinas
24d ago
ARVN
Arvinas Reports Positive Phase 1 Data for ARV-102
Premium
Company Announcements
Arvinas Reports Positive Phase 1 Data for ARV-102
24d ago
8K
ARVN
Regulatory Turbulence: How FDA Disruptions and Budget Cuts Threaten Arvinas Holding Company’s Drug Development Timelines
Premium
Company Announcements
Regulatory Turbulence: How FDA Disruptions and Budget Cuts Threaten Arvinas Holding Company’s Drug Development Timelines
1M ago
ARVN
Arvinas: Strong Pipeline Momentum, De-Risked Cash Runway, and Attractive Risk‑Reward Support Buy Rating
Premium
Ratings
Arvinas: Strong Pipeline Momentum, De-Risked Cash Runway, and Attractive Risk‑Reward Support Buy Rating
2M ago
ARVN
Arvinas Earnings Call: High Science, Tight Cash
Premium
Company Announcements
Arvinas Earnings Call: High Science, Tight Cash
2M ago
ARVN
More ARVN News >

ARVN News on the Web

Arvinas (ARVN) Moves 6.9% Higher: Will This Strength Last?
Zacks
Bullish
Top Executive’s Surprise Stock Move Shakes Up Arvinas Holding Company
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Gossamer Bio (GOSS), High Tide (HITI) and Arvinas Holding Company (ARVN)
TipRanks News
Neutral
Arvinas Buy Rating Driven by Robust ARV-102 LRRK2 Degrader Data and Clear Neurodegeneration Development Path
TipRanks News
Bullish
Analysts Have Conflicting Sentiments on These Healthcare Companies: ProKidney (PROK), HeartFlow, Inc. (HTFL) and Arvinas Holding Company (ARVN)
TipRanks News
Neutral
Wells Fargo Reaffirms Their Buy Rating on Arvinas Holding Company (ARVN)
TipRanks News
Neutral
Balanced View on Arvinas: Early Promise of ARV-102 Offset by Clinical, Safety, and Competitive Uncertainties Supporting a Hold Rating
TipRanks News
Neutral
Arvinas price target raised to $21 from $18 at Citi
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARVN’s Media Buzz Sentiment?
Currently, no data Available
What is ARVN’s weekly average amount of articles?
Currently, no data Available
What is ARVN’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week